MDL-201449

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameMDL-201449
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionTumor necrosis factor inhibitorsAdenosine A3 receptor agonists
TargetsAdenosine A3 receptorTumor necrosis factor
Therapy Area/IndicationsDiabetes MellitusArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSweden
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAventis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAventis +[2] 
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A